Pharmaceutical Policy and Politics
Program Manager: Jody Roberts

In order to advance public dialogue on and analysis of drug research, testing, and regulation, this program area

• Hosts symposia on current issues in drug policy with historical precedents;
• Carries out research to create case studies of changing technologies for pharmaceutical innovation between 1950 and the present; and
• Supports a study of the social and political implications of the international harmonization of regulatory standards for new drug approvals.

Related publications
Perspectives on Risk and Regulation: The FDA at 100, edited by Arthur Daemmrich and Joanna Radin. In celebration of the centennial of the Food and Drug Administration, this article examines the role of chemists in establishing the regulatory framework that made such assurance possible.

Pharmacopolitics, by Arthur Daemmrich. A comparison of regulation, pre-market testing, and post-market surveillance of drugs in the United States and Germany in the 20th century.

Chemical Heritage article
"How Chemists Pushed for Consumer Protection: The Food and Drugs Act of 1906" by John P. Swann. In celebration of the centennial of the Food and Drug Administration, this article examines the role of chemists in establishing the regulatory framework that made such assurance possible.